Literature DB >> 31160299

Physician's role in prescribing opioids in developing countries.

Jorge A Roa1, Alexandra Guevara2, Carolina Guevara2, Jaime Guevara-Aguirre1,2,3.   

Abstract

In developed countries, addressing the growing opioid addiction epidemic is focused on preventive measures, developing better overdose-reversal medications and designing newer strategies to treat addiction. Primary prescribers of the therapeutic use of opioids might play a definite role in the aetiology of the epidemics. Developing countries could be affected by similar issues; however, given that no updated statistics are available, it is possible that their populations undergo problems similar to those for which current data is available. Concerns have arisen regarding synthetic opioid tramadol which, given its fast and potent analgesic effects, low cost and easy availability is widely prescribed. A debate remains as to whether tramadol induces addictive effects like those of stronger analogues such as oxycodone or fentanyl. Here we present a case of tramadol dependence in an Ecuadorian patient and find that substance abuse can occur in normal individuals affected by chronic pain, otherwise treatable with standard methods. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  general practice/family medicine; global health; pain (neurology)

Mesh:

Substances:

Year:  2019        PMID: 31160299      PMCID: PMC6557334          DOI: 10.1136/bcr-2018-227072

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  38 in total

1.  PharmGKB summary: tramadol pathway.

Authors:  Li Gong; Ulrike M Stamer; Mladen V Tzvetkov; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-07       Impact factor: 2.089

Review 2.  Endogenous opioids: biology and function.

Authors:  H Akil; S J Watson; E Young; M E Lewis; H Khachaturian; J M Walker
Journal:  Annu Rev Neurosci       Date:  1984       Impact factor: 12.449

3.  Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Authors:  Laxmaiah Manchikanti; Adam M Kaye; Nebojsa Nick Knezevic; Heath McAnally; Konstantin Slavin; Andrea M Trescot; Susan Blank; Vidyasagar Pampati; Salahadin Abdi; Jay S Grider; Alan D Kaye; Kavita N Manchikanti; Harold Cordner; Christopher G Gharibo; Michael E Harned; Sheri L Albers; Sairam Atluri; Steve M Aydin; Sanjay Bakshi; Robert L Barkin; Ramsin M Benyamin; Mark V Boswell; Ricardo M Buenaventura; Aaron K Calodney; David L Cedeno; Sukdeb Datta; Timothy R Deer; Bert Fellows; Vincent Galan; Vahid Grami; Hans Hansen; Standiford Helm Ii; Rafael Justiz; Dhanalakshmi Koyyalagunta; Yogesh Malla; Annu Navani; Kent H Nouri; Ramarao Pasupuleti; Nalini Sehgal; Sanford M Silverman; Thomas T Simopoulos; Vijay Singh; Daneshvari R Solanki; Peter S Staats; Ricardo Vallejo; Bradley W Wargo; Arthur Watanabe; Joshua A Hirsch
Journal:  Pain Physician       Date:  2017-02       Impact factor: 4.965

4.  A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain.

Authors:  Edgar H Adams; Scott Breiner; Theodore J Cicero; Anne Geller; James A Inciardi; Sidney H Schnoll; Edward C Senay; George E Woody
Journal:  J Pain Symptom Manage       Date:  2006-05       Impact factor: 3.612

5.  Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.

Authors:  Siew Hua Gan; Rusli Ismail; Wan Aasim Wan Adnan; Wan Zulmi
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

6.  Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).

Authors:  Stephen F Butler; Kathrine Fernandez; Christine Benoit; Simon H Budman; Robert N Jamison
Journal:  J Pain       Date:  2008-01-22       Impact factor: 5.820

7.  Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients.

Authors:  Laura L Adams; Robert J Gatchel; Richard C Robinson; Peter Polatin; Noor Gajraj; Martin Deschner; Carl Noe
Journal:  J Pain Symptom Manage       Date:  2004-05       Impact factor: 3.612

Review 8.  Classical conditioning and pain: conditioned analgesia and hyperalgesia.

Authors:  Gonzalo Miguez; Mario A Laborda; Ralph R Miller
Journal:  Acta Psychol (Amst)       Date:  2013-11-22

Review 9.  Suicide by means of opioid overdose in patients with chronic pain.

Authors:  Parvaz Madadi; Nav Persaud
Journal:  Curr Pain Headache Rep       Date:  2014-11

10.  Pain as the fifth vital sign: exposing the vital need for pain education.

Authors:  Natalia E Morone; Debra K Weiner
Journal:  Clin Ther       Date:  2013-10-18       Impact factor: 3.393

View more
  3 in total

Review 1.  Multimechanistic Single-Entity Combinations for Chronic Pain Control: A Narrative Review.

Authors:  Joseph Pergolizzi; Peter Magnusson; Flaminia Coluzzi; Frank Breve; Jo Ann K LeQuang; Giustino Varrassi
Journal:  Cureus       Date:  2022-06-16

2.  The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.

Authors:  Nicole Atkins; Karim Mukhida
Journal:  Can J Pain       Date:  2022-09-01

3.  Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study.

Authors:  E Jennifer Edelman; Yu Li; Declan Barry; Jennifer Brennan Braden; Stephen Crystal; Robert D Kerns; Julie R Gaither; Kirsha S Gordon; Ajay Manhapra; Jessica S Merlin; Brent A Moore; Benjamin J Oldfield; Lesley S Park; Christopher T Rentsch; Melissa Skanderson; Emily C Williams; Amy C Justice; Janet P Tate; William C Becker; Brandon D L Marshall
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.